참고문헌
- Kiyosawa K, Tanaka E, Sodeyama T, Furuta K, Usuda S, Yousuf M, Furuta S: Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Jpn J Cancer Res 81;1089-1091, 1990 https://doi.org/10.1111/j.1349-7006.1990.tb02517.x
- Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341;556-562, 1999 https://doi.org/10.1056/NEJM199908193410802
- Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B: Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 77;4781-4793, 2003 https://doi.org/10.1128/JVI.77.8.4781-4793.2003
- Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, Wang XH, Ray SC, Thomas DL: Cross-genotype immunity to hepatitis C virus. J Virol 78;1575-1581, 2004 https://doi.org/10.1128/JVI.78.3.1575-1581.2004
- Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, Pezzanera M, Tafi R, Arcuri M, Fattori E, Lahm A, Luzzago A, Vitelli A, Colloca S, Cortese R, Nicosia A: A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med 12;190- 197, 2006 https://doi.org/10.1038/nm1353
- Youn JW, Park SH, Lavillette D, Cosset FL, Yang SH, Lee CG, Jin HT, Kim CM, Shata MT, Lee DH, Pfahler W, Prince AM, Sung YC: Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee. Hepatology 42;1429-1436, 2005 https://doi.org/10.1002/hep.20934
- Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J: Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 32;618-625, 2000
- Pertmer TM, Roberts TR, Haynes JR: Influenza virus nucleoprotein- specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 70;6119-6125, 1996
- Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90;11478-11482, 1993 https://doi.org/10.1073/pnas.90.24.11478
- Choi SY, Suh YS, Cho JH, Jin HT, Chang J, Sung YC: Enhancement of DNA vaccine-induced immune responses by influenza virus NP gene. Immune Netw 9;169-178, 2009 https://doi.org/10.4110/in.2009.9.5.169
- Barouch DH, Letvin NL, Seder RA: The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol Rev 202;266-274, 2004 https://doi.org/10.1111/j.0105-2896.2004.00200.x
- Appasamy PM: Biological and clinical implications of interleukin- 7 and lymphopoiesis. Cytokines Cell Mol Ther 5;25- 39, 1999
- Faltynek CR, Wang S, Miller D, Young E, Tiberio L, Kross K, Kelley M, Kloszewski E: Administration of human recombinant IL-7 to normal and irradiated mice increases the numbers of lymphocytes and some immature cells of the myeloid lineage. J Immunol 149;1276-1282, 1992
- Komschlies KL, Gregorio TA, Gruys ME, Back TC, Faltynek CR, Wiltrout RH: Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases. J Immunol 152;5776-5784, 1994
- Morrissey PJ, Goodwin RG, Nordan RP, Anderson D, Grabstein KH, Cosman D, Sims J, Lupton S, Acres B, Reed SG: Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. J Exp Med 169;707-716, 1989 https://doi.org/10.1084/jem.169.3.707
- Alderson MR, Sassenfeld HM, Widmer MB: Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine- activated killer cells from human peripheral blood.J Exp Med 172;577-587, 1990 https://doi.org/10.1084/jem.172.2.577
- Schluns KS, Kieper WC, Jameson SC, Lefrancois L: Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo. Nat Immunol 1;426-432, 2000 https://doi.org/10.1038/80868
- Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD: IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A 98;8732-8737, 2001 https://doi.org/10.1073/pnas.161126098
- Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB: Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci U S A 92;5491-5495, 1995 https://doi.org/10.1073/pnas.92.12.5491
- Maeurer MJ, Trinder P, Hommel G, Walter W, Freitag K, Atkins D, Störkel S: Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect Immun 68;2962-2970, 2000 https://doi.org/10.1128/IAI.68.5.2962-2970.2000
- Sin JI, Kim J, Pachuk C, Weiner DB: Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2- type immune responses in vivo. Clin Diagn Lab Immunol 7;751-758, 2000
- Calarota SA, Dai A, Trocio JN, Weiner DB, Lori F, Lisziewicz J: IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine. Vaccine 26;5188-5195, 2008 https://doi.org/10.1016/j.vaccine.2008.03.067
- Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL: Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest 115;1177-1187, 2005 https://doi.org/10.1172/JCI200523134
- Geiselhart LA, Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL: IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol 166;3019-3027, 2001 https://doi.org/10.4049/jimmunol.166.5.3019
- Lee KJ, Suh YA, Cho YG, Cho YS, Ha GW, Chung KH, Hwang JH, Yun YD, Lee DS, Kim CM, Sung YC: Hepatitis C virus E2 protein purified from mammalian cells is frequently recognized by E2-specific antibodies in patient sera. J Biol Chem 272;30040-30046, 1997 https://doi.org/10.1074/jbc.272.48.30040
- Sheehan JJ, Tsirka SE: Fibrin-modifying serine proteases thrombin, tPA, and plasmin in ischemic stroke: a review. Glia 50;340-350, 2005 https://doi.org/10.1002/glia.20150
- Youn JW, Park SH, Cho JH, Sung YC: Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization. J Virol 77;11596-11602, 2003 https://doi.org/10.1128/JVI.77.21.11596-11602.2003
- Park SH, Yang SH, Lee CG, Youn JW, Chang J, Sung YC: Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost. Vaccine 21;4555-4564, 2003 https://doi.org/10.1016/S0264-410X(03)00499-7
- Park SH, Lee SR, Hyun BH, Kim BM, Sung YC: Codelivery of PEG-IFN-alpha inhibits HCV DNA vaccine-induced T cell responses but not humoral responses in African green monkeys. Vaccine 26;3978-3983, 2008 https://doi.org/10.1016/j.vaccine.2008.05.017
- Ma A, Koka R, Burkett P: Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu Rev Immunol 24;657-679, 2006 https://doi.org/10.1146/annurev.immunol.24.021605.090727
- Sinha ML, Fry TJ, Fowler DH, Miller G, Mackall CL: Interleukin 7 worsens graft-versus-host disease. Blood 100;2642-2649, 2002 https://doi.org/10.1182/blood-2002-04-1082
- Milne CD, Paige CJ: IL-7: a key regulator of B lymphopoiesis. Semin Immunol 18;20-30, 2006 https://doi.org/10.1016/j.smim.2005.10.003
- Morrissey PJ, Conlon P, Charrier K, Braddy S, Alpert A, Williams D, Namen AE, Mochizuki D: Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. J Immunol 147;561-568, 1991
피인용 문헌
- Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection vol.90, pp.5, 2016, https://doi.org/10.1128/jvi.02768-15
- Interleukin-7 and Immunosenescence vol.2017, pp.None, 2010, https://doi.org/10.1155/2017/4807853
- Recombinant chicken interleukin-7 as a potent adjuvant increases the immunogenicity and protection of inactivated infectious bursal disease vaccine vol.49, pp.None, 2010, https://doi.org/10.1186/s13567-017-0497-3
- Co-Expression of Chicken IL-2 and IL-7 Enhances the Immunogenicity and Protective Efficacy of a VP2-Expressing DNA Vaccine against IBDV in Chickens vol.11, pp.5, 2010, https://doi.org/10.3390/v11050476
- Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer vol.11, pp.None, 2010, https://doi.org/10.3389/fimmu.2020.01557
- The Broad Immunomodulatory Effects of IL-7 and Its Application In Vaccines vol.12, pp.None, 2010, https://doi.org/10.3389/fimmu.2021.680442
- Hepatitis C virus DNA vaccines: a systematic review vol.18, pp.1, 2021, https://doi.org/10.1186/s12985-021-01716-8